« Previous
Next »
The Journal of Urology
Volume 183, Issue 5
, Pages 1667-1668
, May 2010
Are We Making Significant Progress in the Diagnosis and Management of Bladder Cancer?
References
- . Bladder cancer. Lancet. 2009;374:239
- SEER Cancer Statistics Review, 1975–2004. Bethesda: National Cancer Institute; 2007;
- . Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol. 1976;116:180
- Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol. 2006;176:2414
- Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J Urol. 1985;133:403
- Near misses in bladder cancer—an airline safety approach to urology. Ann R Coll Surg Engl. 2003;85:378
- Patterns of hematuria referral to urologists: does a gender disparity exist?. Urology. 2008;72:498
- . Evaluation and work-up of hematuria among primary care physicians in Miami-Dade County: an anonymous questionnaire-based survey. J Urol. 2007;177(suppl.):357;abstract 1082
- Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy. Eur Urol. 2004;45:292
- . Genetic alterations in urothelial bladder carcinoma: an updated review. Cancer. 2006;106:1205
- Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer. J Urol. 2010;183:68
PII: S0022-5347(10)02640-6
doi: 10.1016/j.juro.2010.02.2376
© 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc All rights reserved.
« Previous
Next »
The Journal of Urology
Volume 183, Issue 5
, Pages 1667-1668
, May 2010

